Indeed, by using the three inhibitors directed against AKT, mTORC1/2 and MEK1/2 we observed synergistic effects in vitro on cell viability of both MPNST cell lines analysed, in comparison to the dual AKT and mTORC1/2 treatment alone. Here, AKT1 is linked to malignant peripheral nerve sheath tumor.